Nasir Hassan Luck
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nasir Hassan Luck has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Abbas Ali Tasneem
Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, SIUT, Pakistan
1 shared publication - Elin Hoffmann Dahl
Medical Department, Haukeland University Hospital, Bergen, Norway
1 shared publication - Hassaan Zahid
Medicins Sans Frontiers, Juba, South Sudan
1 shared publication - Hina Ismail
Sindh Institute of Urology and Transplantation (SIUT), Karachi, Pakistan
1 shared publication - Marta Aleksandra Balinska
Department of Public Health, Centre Hospitalier Universitaire de Nice, Université Nice Côte d’Azur, France
1 shared publication - Muhammad Adeel
Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, SIUT, Pakistan
1 shared publication
Latest Publications
- Open Access
- 1 October 2023
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 10 (10) , e01160
Ectopic Hepatocellular Carcinoma Manifesting as Paraspinal Mass: An Unusual Entity
- 1 October 2023
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 10 (10) , e01160
Open AccessEctopic Hepatocellular Carcinoma Manifesting as Paraspinal Mass: An Unusual Entity
- Open Access
- 23 May 2022
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2022 (5) , omac049
DAA treatment failures in a low-resource setting with a high burden of hepatitis C infections: a case series
Globally, 58 million people are living with hepatitis C virus (HCV) infection and 1.5 million new patients are infected every year. The advent of direct acting antivirals (DAAs) has revolutionized the treatment of HCV, opening the door to the ambitious World Health Organization HCV infection elimination strategy by 2030. However, emerging resistance to DAAs could jeopardize any hope of achieving these targets. We discuss a series of 18 patients within a resource-limited setting, who after failing standard sofosbuvir-daclatasvir-based regimen also failed to respond to advanced pan-genotypic treatment regimens, i.e. sofosbuvir-velpatasvir, sofosbuvir-velpatasvir-ribavirin and sofosbuvir-velpatasvir-voxilaprevir. To avoid the spread of refractory HCV strains within the existing epidemic, we call for increased attention and research regarding patients failing treatment on standard pan-genotypic regimens and the spread of HCV-resistant strains within the communities.
- 23 May 2022
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2022 (5) , omac049
Open AccessDAA treatment failures in a low-resource setting with a high burden of hepatitis C infections: a case series
Globally, 58 million people are living with hepatitis C virus (HCV) infection and 1.5 million new patients are infected every year. The advent of direct acting antivirals (DAAs) has revolutionized the treatment of HCV, opening the door to the ambitious World Health Organization HCV infection elimination strategy by 2030. However, emerging resistance to DAAs could jeopardize any hope of achieving these targets. We discuss a series of 18 patients within a resource-limited setting, who after failing standard sofosbuvir-daclatasvir-based regimen also failed to respond to advanced pan-genotypic treatment regimens, i.e. sofosbuvir-velpatasvir, sofosbuvir-velpatasvir-ribavirin and sofosbuvir-velpatasvir-voxilaprevir. To avoid the spread of refractory HCV strains within the existing epidemic, we call for increased attention and research regarding patients failing treatment on standard pan-genotypic regimens and the spread of HCV-resistant strains within the communities.
- Open Access
- 8 October 2021
- Published by Springer Nature in Cureus
- Vol. 13 (10)
Liver Elastography as a Predictor of Esophageal Varices in Patients With Cirrhosis
Liver cirrhosis is an advanced consequence of a long-standing liver disease that can lead to portal hypertension which subsequently can manifest as life-threatening variceal bleeding. The present study aimed to determine liver stiffness by shear wave elastography (SWE) to predict esophageal varices (EV) in patients with chronic liver diseases. A prospective observational study was performed at the Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Karachi between November 2020 and July 2021. Individuals aged between 18 and 50 years, irrespective of gender, with diagnosed chronic liver disease >6 months were eligible to partake in the study. Patients with concomitant renal failure, severe ascites, severe life-threatening co-morbidities including congestive heart failure NYHA-III and IV, acute asthmatic attack, and recent myocardial infarction (MI) were excluded from the study. SWE was determined in all patients to measure liver stiffness. Esophagogastroduodenoscopy (EGD) was performed to visualize the esophageal varices. All findings were recorded. A 2 × 2 table was applied to determine the sensitivity, specificity, positive, and diagnostic accuracy for SWE by taking endoscopy as the definitive test. A total of 204 patients were included in the study. Mean age of 40.37 ± 15.20 years was observed. The mean liver size of patients was 12.38 ± 2.06 cm and the mean liver stiffness of patients was 19.97 ± 8.6. The sensitivity and specificity of liver elastography were 44.90% and 51.90%, respectively. Furthermore, the positive and negative predictive values were 53.00% and 99.39%, respectively. The diagnostic accuracy of the test was 51.86%. Even though the diagnostic gold standard for the detection of varices is EGD, liver elastography provides a less invasive procedure to assess for varices in patients with cirrhotic liver disease. The present study concluded that liver elastography is a non-invasive and indirect valuable tool to predict the presence of esophageal varices with sensitivity and specificity of 44.90% and 51.90%, respectively.
- 8 October 2021
- Published by Springer Nature in Cureus
- Vol. 13 (10)
Open AccessLiver Elastography as a Predictor of Esophageal Varices in Patients With Cirrhosis
Liver cirrhosis is an advanced consequence of a long-standing liver disease that can lead to portal hypertension which subsequently can manifest as life-threatening variceal bleeding. The present study aimed to determine liver stiffness by shear wave elastography (SWE) to predict esophageal varices (EV) in patients with chronic liver diseases. A prospective observational study was performed at the Department of Hepatogastroenterology, Sindh Institute of Urology and Transplantation, Karachi between November 2020 and July 2021. Individuals aged between 18 and 50 years, irrespective of gender, with diagnosed chronic liver disease >6 months were eligible to partake in the study. Patients with concomitant renal failure, severe ascites, severe life-threatening co-morbidities including congestive heart failure NYHA-III and IV, acute asthmatic attack, and recent myocardial infarction (MI) were excluded from the study. SWE was determined in all patients to measure liver stiffness. Esophagogastroduodenoscopy (EGD) was performed to visualize the esophageal varices. All findings were recorded. A 2 × 2 table was applied to determine the sensitivity, specificity, positive, and diagnostic accuracy for SWE by taking endoscopy as the definitive test. A total of 204 patients were included in the study. Mean age of 40.37 ± 15.20 years was observed. The mean liver size of patients was 12.38 ± 2.06 cm and the mean liver stiffness of patients was 19.97 ± 8.6. The sensitivity and specificity of liver elastography were 44.90% and 51.90%, respectively. Furthermore, the positive and negative predictive values were 53.00% and 99.39%, respectively. The diagnostic accuracy of the test was 51.86%. Even though the diagnostic gold standard for the detection of varices is EGD, liver elastography provides a less invasive procedure to assess for varices in patients with cirrhotic liver disease. The present study concluded that liver elastography is a non-invasive and indirect valuable tool to predict the presence of esophageal varices with sensitivity and specificity of 44.90% and 51.90%, respectively.